Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281234 ↗Kurz gefasst
Fallbericht in der Zeitschrift PLOS ONE, 2023. Verfasst von Gunilla Malm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Pre-Eclampsia, Vitamin D Deficiency. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council for Sustainable Development, European Union, Interreg VÖKS, Lund University.
Abstract (Originalsprache)
Background
Preeclampsia is considered a major cause of maternal and fetal morbidity and mortality. The aim of the present case-control study in Sweden was to assess the hypothesized association between low serum vitamin D concentrations in early pregnancy and the risk of developing preeclampsia since vitamin D may play a role in early placental development.
Methods
The study included 296 women diagnosed with preeclampsia (cases) and 580 healthy pregnant women (controls). Serum samples were obtained from a biobank of samples collected in early pregnancy including almost all pregnancies in Southern Sweden. Concentrations of 25-hydroxyvitamin D3 (vitamin D) were analyzed using liquid chromatography-tandem-mass-spectrometry (LC/MS/MS). The cases were divided into two categories: i) infants were born before gestational week 34 (early onset) and/or born small-for-gestational age (SGA)(n = 51), ii) and others defined as late onset (n = 245). Vitamin D concentrations were analyzed both as a continuous and a categorized variable.
Results
When all preeclampsia cases were included in the analyses no consistent patterns were observed. However, the median serum concentrations of vitamin D were significantly lower among the cases who were early onset and/or were born SGA (median 39.2 nmol/L, range 1.2–93.6) as compared to the controls (49.0 nmol/L, 0.1–219; p = 0.01). In addition, high concentrations were statistically significantly associated with a decreased risk of preeclampsia (>66.9 vs ≤30.1 nmol/L; crude OR 0.39, 95% CI 0.16–0.96). When potential confounders were included in the models the associations were even more pronounced.
Conclusions
Our results support the hypothesis that vitamin D deficiency is a risk factor for preeclampsia, but only in preeclampsia cases who were early-onset and/or were born SGA. Preeclampsia is not a homogenous condition and more studies are needed before vitamin D supplementation during pregnancy can be recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, Lund, Sweden.
- Tornblad Institute, Lund University, Lund, Sweden.
- Department of Translational Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Gunilla Malm, Stefan R Hansson
Förderung
- Swedish Research Council for Sustainable Development
- European Union, Interreg VÖKS
- Lund University
Zitieren
APA
Malm, G., Lindh, C. H., Hansson, S. R., Källén, K., Malm, J., & Rylander, L. (2023). Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden. PLOS ONE. https://doi.org/10.1371/journal.pone.0281234
Vancouver
Malm G, Lindh CH, Hansson SR, Källén K, Malm J, Rylander L. Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden. PLOS ONE. 2023. doi:10.1371/journal.pone.0281234
BibTeX
@article{Malm2023,
author = {Malm, Gunilla and Lindh, Christian H and Hansson, Stefan R and Källén, Karin and Malm, Johan and Rylander, Lars},
title = {Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281234}
}
EUVIMED